{"id":"https://openalex.org/W4362624664","doi":"https://doi.org/10.1158/1535-7163.22522767.v1","title":"Supplementary Figure from Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors","display_name":"Supplementary Figure from Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362624664","doi":"https://doi.org/10.1158/1535-7163.22522767.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22522767.v1","doi":"https://doi.org/10.1158/1535-7163.22522767.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22522767.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.22522767.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061790968","display_name":"Sakshi Tomar","orcid":"https://orcid.org/0000-0001-5994-4178","observed_orcids":["https://orcid.org/0000-0001-5994-4178"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sakshi Tomar","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5994-4178","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100677413","display_name":"Jingli Zhang","orcid":"https://orcid.org/0000-0002-8590-5233","observed_orcids":["https://orcid.org/0000-0002-8590-5233"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jingli Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8590-5233","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051426284","display_name":"Manakamana Khanal","orcid":"https://orcid.org/0000-0002-8821-2221","observed_orcids":["https://orcid.org/0000-0002-8821-2221"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manakamana Khanal","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8821-2221","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091769570","display_name":"Jessica Hong","orcid":"https://orcid.org/0000-0001-8726-4575","observed_orcids":["https://orcid.org/0000-0001-8726-4575"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jessica Hong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8726-4575","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010663233","display_name":"Abhilash Karavattu Venugopalan","orcid":"https://orcid.org/0000-0003-4505-2050","observed_orcids":["https://orcid.org/0000-0003-4505-2050"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abhilash Venugopalan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4505-2050","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000332889","display_name":"Qun Jiang","orcid":"https://orcid.org/0000-0003-1611-2595","observed_orcids":["https://orcid.org/0000-0003-1611-2595","https://orcid.org/0000-0001-9414-4635"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qun Jiang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1611-2595","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039792443","display_name":"Manjistha Sengupta","orcid":"https://orcid.org/0000-0001-6406-946X","observed_orcids":["https://orcid.org/0000-0001-6406-946X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manjistha Sengupta","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6406-946X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024934444","display_name":"Markku Miettinen","orcid":"https://orcid.org/0000-0002-3282-8107","observed_orcids":["https://orcid.org/0000-0002-3282-8107"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Markku Miettinen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3282-8107","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100341038","display_name":"Nan Li","orcid":"https://orcid.org/0000-0002-1498-7139","observed_orcids":["https://orcid.org/0000-0002-1498-7139"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nan Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1498-7139","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056573254","display_name":"Ira H Pastan","orcid":"https://orcid.org/0000-0002-9223-0270","observed_orcids":["https://orcid.org/0000-0002-9223-0270"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ira Pastan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9223-0270","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036066519","display_name":"Mitchell Ho","orcid":"https://orcid.org/0000-0002-9152-5405","observed_orcids":["https://orcid.org/0000-0002-9152-5405"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mitchell Ho","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9152-5405","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5029872582","display_name":"Raffit Hassan","orcid":"https://orcid.org/0000-0002-4012-3633","observed_orcids":["https://orcid.org/0000-0002-4012-3633"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raffit Hassan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4012-3633","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mesothelin","display_name":"mesothelin","score":0.828000009059906},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.9700000286102295},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.7630000114440918},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.8579999804496765},{"id":"https://openalex.org/keywords/tumor-infiltration","display_name":"tumor infiltration","score":0.9399999976158142},{"id":"https://openalex.org/keywords/t-cell-persistence","display_name":"T cell persistence","score":0.921999990940094},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7379999756813049}],"concepts":[{"id":"https://openalex.org/C2777045440","wikidata":"https://www.wikidata.org/wiki/Q14914057","display_name":"Mesothelin","level":3,"score":0.9483349919319153},{"id":"https://openalex.org/C153400128","wikidata":"https://www.wikidata.org/wiki/Q3150731","display_name":"Infiltration (HVAC)","level":2,"score":0.7004830241203308},{"id":"https://openalex.org/C2781009140","wikidata":"https://www.wikidata.org/wiki/Q7170389","display_name":"Persistence (discontinuity)","level":2,"score":0.6996272802352905},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.5887240171432495},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.4870198369026184},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4619804620742798},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.43673956394195557},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4327634871006012},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3277136981487274},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32251596450805664},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3088653087615967},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.26527056097984314},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.1991012692451477},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.15781566500663757},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1262461245059967},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0877084732055664},{"id":"https://openalex.org/C127313418","wikidata":"https://www.wikidata.org/wiki/Q1069","display_name":"Geology","level":0,"score":0.07580742239952087},{"id":"https://openalex.org/C187320778","wikidata":"https://www.wikidata.org/wiki/Q1349130","display_name":"Geotechnical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.22522767.v1","doi":"https://doi.org/10.1158/1535-7163.22522767.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22522767.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22522767","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_from_Development_of_Highly_Effective_Anti-Mesothelin_hYP218_Chimeric_Antigen_Receptor_T_Cells_With_Increased_Tumor_Infiltration_and_Persistence_for_Treating_Solid_Tumors/22522767","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22522767.v1","doi":"https://doi.org/10.1158/1535-7163.22522767.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22522767.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4225286294","https://openalex.org/W4392689833","https://openalex.org/W4213235748","https://openalex.org/W4393076044","https://openalex.org/W4295226699","https://openalex.org/W4293053555","https://openalex.org/W2336405815","https://openalex.org/W4392721733","https://openalex.org/W7125096331","https://openalex.org/W4247597836"],"abstract_inverted_index":{"Supplementary":[0],"Figure":[1],"from":[2],"Development":[3],"of":[4],"Highly":[5],"Effective":[6],"Anti-Mesothelin":[7],"hYP218":[8],"Chimeric":[9],"Antigen":[10],"Receptor":[11],"T":[12],"Cells":[13],"With":[14],"Increased":[15],"Tumor":[16],"Infiltration":[17],"and":[18],"Persistence":[19],"for":[20],"Treating":[21],"Solid":[22],"Tumors":[23]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2023-04-07T00:00:00"}